Egetis Therapeutics AB (publ) (STO:EGTX)
5.01
+0.03 (0.60%)
Mar 23, 2026, 5:19 PM CET
Revenue by Segment
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.